Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease
Abstract Background It is now acknowledged that the input of patients in health outcome assessment is vital to understanding the impact of diseases and interventions for those diseases. This study is the first report of patient-reported outcome measures (PROM) in a large cohort of patients with type...
Main Authors: | Tama Dinur, Majdolen Istaiti, Dafna Frydman, Michal Becker-Cohen, Jeff Szer, Ari Zimran, Shoshana Revel-Vilk |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-01544-z |
Similar Items
-
Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations
by: Tama Dinur, et al.
Published: (2021-07-01) -
Long Term Follow-Up of 103 Untreated Adult Patients with Type 1 Gaucher Disease
by: Tama Dinur, et al.
Published: (2019-10-01) -
Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease
by: Noa Hurvitz, et al.
Published: (2019-06-01) -
Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review
by: Shoshana Revel-Vilk, et al.
Published: (2020-09-01) -
Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease
by: Yishay Weill, et al.
Published: (2020-09-01)